Profile data is unavailable for this security.
About the company
Advanced Medical Solutions Group plc is engaged in the design, development, manufacture and distribution of materials for use in advanced woundcare products and surgical dressings, as well as medical adhesives and sutures for closing and sealing tissue. It operates through four segments: Branded Direct, Branded Distributed, OEM (Original Equipment Manufacturer) and Bulk Materials. Its Branded Direct segment is engaged in selling, marketing and innovation of its branded products sold directly by its sales teams. Its Branded Distributed segment is engaged in distribution, marketing and innovation of its brands sold by distributors in markets not serviced by its sales team. Its OEM segment is engaged in selling, marketing and innovation of its products supplied to partners under their brands. Its Bulk Materials segment is engaged in selling, marketing and innovation of bulk materials to medical device partners and convertors. Its products include ActivHeal, LiquiBand and RESORBA.
- Revenue in GBP (TTM)103.69m
- Net income in GBP20.57m
- Incorporated1993
- Employees654.00
- LocationAdvanced Medical Solutions Group PLCPremier Park, 33 Road OneWINSFORD CW7 3RTUnited KingdomGBR
- Phone+44 160 686 3500
- Fax+44 160 686 3600
- Websitehttp://www.admedsol.com/
Mergers & acquisitions
| Acquired company | AMS:LSE since announced | Transaction value |
|---|---|---|
| Sealantis Ltd | -14.26% | 25.00m |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Indivior PLC | 689.20m | 165.13m | 301.66m | 1.02k | 1.91 | 1.54 | 1.65 | 0.4377 | 0.2163 | 0.2163 | 0.8998 | 0.2674 | 0.5653 | 1.75 | 3.84 | 673,044.20 | 13.55 | 19.01 | 26.54 | 58.16 | 85.04 | 89.95 | 23.96 | 19.15 | 1.97 | -- | 0.5368 | 9.09 | -8.05 | -3.74 | 273.97 | -11.00 | 68.71 | -- |
| Silence Therapeutics plc | 0.00 | -17.93m | 308.65m | 45.00 | -- | 10.47 | -- | -- | -0.2530 | -0.2530 | 0.00 | 0.3764 | 0.00 | -- | -- | 0.00 | -46.23 | -19.56 | -50.43 | -20.44 | -- | -- | -- | -5,768.04 | -- | -- | 0.00 | -- | -100.00 | -- | -1,037.89 | -- | 9.39 | -- |
| Alliance Pharma plc | 129.76m | 21.67m | 389.35m | 210.00 | 18.07 | 1.49 | 16.54 | 3.00 | 0.041 | 0.041 | 0.2453 | 0.4969 | 0.3214 | 2.94 | 6.26 | 617,904.80 | 5.37 | 6.62 | 7.00 | 7.87 | 62.83 | 58.75 | 16.70 | 21.10 | 0.4659 | 8.46 | 0.2672 | 31.80 | 16.30 | 21.16 | -36.33 | 13.88 | -21.58 | 10.02 |
| Oxford BioMedica plc | 63.59m | -7.81m | 429.97m | 377.00 | -- | 5.36 | -- | 6.76 | -0.1146 | -0.1146 | 0.9181 | 1.04 | 0.553 | 6.02 | 3.04 | 168,684.30 | -6.79 | -14.68 | -9.41 | -19.78 | 61.64 | 60.85 | -12.28 | -24.62 | 2.12 | -1.07 | 0.0955 | -- | 77.65 | 65.52 | 183.63 | -- | 61.04 | -- |
| Vectura Group PLC | 172.30m | -78.00m | 520.17m | 453.00 | -- | 1.09 | 1,040.34 | 3.02 | -0.1267 | -0.1267 | 0.28 | 0.7798 | 0.2739 | 2.92 | 4.53 | 380,353.20 | -12.40 | -- | -13.67 | -- | 56.99 | -- | -45.27 | -- | 2.41 | -- | 0.017 | -- | 8.45 | -- | -1.03 | -- | -- | -- |
| Advanced Medical Solutions Group plc | 103.69m | 20.57m | 535.90m | 654.00 | 26.23 | 2.93 | 21.02 | 5.17 | 0.0951 | 0.0951 | 0.4794 | 0.8511 | 0.5146 | 2.78 | 4.92 | 158,548.90 | 10.21 | 12.43 | 10.96 | 13.63 | 60.40 | 59.28 | 19.84 | 20.59 | 6.08 | 106.25 | 0.0497 | 12.00 | 5.87 | 11.51 | 11.69 | 14.62 | 18.16 | 17.08 |
| Puretech Health PLC | 15.63m | -5.67m | 623.85m | 225.00 | -- | 2.28 | -- | 39.92 | -0.0228 | -0.0228 | 0.0543 | 0.9611 | 0.0383 | -- | 4.32 | 69,455.51 | -13.04 | -28.57 | -17.99 | -45.76 | -- | -- | -340.74 | -865.69 | -- | -- | 0.2374 | -- | 718.46 | 19.53 | -264.91 | -- | 50.17 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Octopus Investments Ltd.as of 08 Apr 2019 | 22.21m | 10.34% |
| AXA Investment Managers UK Ltd.as of 08 Apr 2019 | 17.22m | 8.02% |
| Hargreave Hale Ltd.as of 08 Apr 2019 | 14.37m | 6.69% |
| Investec Wealth & Investment Ltd.as of 08 Apr 2019 | 10.15m | 4.73% |
| Groupama Asset Management SAas of 08 Apr 2019 | 9.29m | 4.33% |
| Aviva Investors Global Services Ltd.as of 08 Apr 2019 | 8.43m | 3.93% |
| BlackRock Investment Management (UK) Ltd.as of 29 Oct 2019 | 6.86m | 3.19% |
| Kames Capital Plcas of 08 Apr 2019 | 6.56m | 3.06% |
| CA Indosuez Wealth (Private Banking Europe)as of 02 Aug 2019 | 5.30m | 2.47% |
| Schroder Investment Management Ltd.as of 02 Aug 2019 | 4.62m | 2.15% |
